Rossari Biotech

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE02A801020
  • NSEID: ROSSARI
  • BSEID: 543213
INR
490.40
9.95 (2.07%)
BSENSE

May 06

BSE+NSE Vol: 1.73 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Titan Biotech
Tatva Chintan
Bhansali Engg.
Fineotex Chem
Jubilant Agri
NOCIL
DDev Plastiks
Rossari Biotech
Styrenix Perfor.
Foseco India
Camlin Fine

Why is Rossari Biotech Ltd ?

1
Negative results in Mar 26
  • OPERATING PROFIT TO INTEREST(Q) Lowest at 8.53 times
  • DEBT-EQUITY RATIO(HY) Highest at 0.33 times
  • INTEREST(Q) Highest at Rs 9.06 cr
2
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -26.22% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Rossari Biotech for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Rossari Biotech
-26.23%
-0.84
31.17%
Sensex
-3.33%
-0.25
13.43%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
27.57%
EBIT Growth (5y)
15.39%
EBIT to Interest (avg)
9.37
Debt to EBITDA (avg)
0.60
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
1.55
Tax Ratio
26.32%
Dividend Payout Ratio
2.11%
Pledged Shares
0
Institutional Holding
20.38%
ROCE (avg)
16.27%
ROE (avg)
11.80%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
18
Industry P/E
42
Price to Book Value
2.02
EV to EBIT
14.50
EV to EBITDA
10.49
EV to Capital Employed
1.83
EV to Sales
1.25
PEG Ratio
1.92
Dividend Yield
NA
ROCE (Latest)
12.59%
ROE (Latest)
11.19%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
NET SALES(Q)

Highest at Rs 684.86 cr

PBDIT(Q)

Highest at Rs 77.25 cr.

PAT(Q)

Highest at Rs 45.97 cr.

EPS(Q)

Highest at Rs 8.30

-13What is not working for the Company
OPERATING PROFIT TO INTEREST(Q)

Lowest at 8.53 times

DEBT-EQUITY RATIO(HY)

Highest at 0.33 times

INTEREST(Q)

Highest at Rs 9.06 cr

Loading Valuation Snapshot...

Here's what is working for Rossari Biotech

Net Sales - Quarterly
Highest at Rs 684.86 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 77.25 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 45.97 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 45.97 cr has Grown at 33.5% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 34.42 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 8.30
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Rossari Biotech

Operating Profit to Interest - Quarterly
Lowest at 8.53 times and Fallen
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio - Half Yearly
Highest at 0.33 times and Grown
each half year in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest - Quarterly
Highest at Rs 9.06 cr
in the last five quarters and Increased by 18.12 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Non Operating Income - Quarterly
Highest at Rs 19.07 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income